U
Ukrainian Center of Tomotherapy LLC | Kropyvnytskyi, Ukraine
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Platinum
/Pembrolizumab
Durvalumab
MK-1084
MK-3475A±MK-1084
Calderasib
Pembrolizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Locations recently updated
Researchers are looking for new ways to treat locally advanced non-small cell lung cancer (NSCLC) that is unresected and has a gene mutation called K...
Enrolling
Non-small Cell Lung Cancer
Drug: Calderasib
Biological: Durvalumab
Locations recently updated
This is a phase 3, randomized, double-blind study of adjuvant calderasib plus subcutaneous pembrolizumab and berahyaluronidase alfa (MK-3475A) versus...
Enrolling
Non-small Cell Lung Cancer
Drug: Calderasib
Drug: Placebo
The purpose of this study is to evaluate pembrolizumab (MK-3475) subcutaneous (SC) administration as the first-line therapy in the treatment of metas...
Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Cisplatin
Biological: Pembrolizumab IV
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems